Stock Events

Stock Events

Apellis Pharmaceuticals (1JK.F) Q4 2024 Earnings

5NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.67

-0.54

-0.41

-0.27

Details

Expected EPS

-0.27063877919999996

Actual EPS

-0.422096

Surprise EPS

-0.15

Surprise Percent

+55.96%

Description

Apellis Pharmaceuticals (1JK.F) has reported earnings of -0.422096 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.